AzureCell is a biotech startup developing engineered neuronal cell therapies for Parkinson’s disease. By combining genetic neuroprotection, adaptive synthetic circuits, and automated manufacturing, AzureCell aims to deliver durable, scalable regenerative treatments that overcome survival, safety, and cost barriers of current cell therapies and enable expansion to other neurodegenerative diseases.